Transforming Clinical Trial Data into Insights with Rivia
Abcentra has achieved enhanced control, efficiency, and a deeper comprehension of their data by implementing Rivia's integrated approach. Supporting their cardiovascular clinical development, this is crucial to maximise outputs of their research efforts.
Enabling better clinical understanding and saving time
Calypso Biotech, developing first-in-class therapies for Celiac Disease and Eosinophilic Esophagitis, adopted Rivia in Q3 2022 for its powerful data integration capabilities. Dr. Houbiers, their Chief Medical Officer, explains how Rivia saves time and enhances understanding
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.